Woods SW, Bearden CE, Sabb FW, et al. Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit. Schizophr Res. 2020. doi:10.1016/j.schres.2020.04.020
Publications
Raffield LM, Dang H, Pratte KA, et al. Comparison of Proteomic Assessment Methods in Multiple Cohort Studies. Proteomics. 2020:e1900278. doi:10.1002/pmic.201900278
van de Geijn B, Finucane H, Gazal S, et al. Annotations capturing cell type-specific TF binding explain a large fraction of disease heritability. Hum Mol Genet. 2020;29(7):1057-1067. doi:10.1093/hmg/ddz226
Shu S, Wu HJ, Ge JY, et al. Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer. Mol Cell. 2020. doi:10.1016/j.molcel.2020.04.027
Paketci C, Edem P, Hiz S, et al. Successful treatment of intractable epilepsy with ketogenic diet therapy in twins with ALG3-CDG. Brain Dev. 2020. doi:10.1016/j.braindev.2020.04.008
Castilla-Vallmanya L, Selmer KK, Dimartino C, et al. Phenotypic spectrum and transcriptomic profile associated with germline variants in TRAF7. Genet Med. 2020. doi:10.1038/s41436-020-0792-7
Hernández-Alonso P, Becerra-Tomás N, Papandreou C, et al. Plasma Metabolomics Profiles were Associated with the Amount and Source of Protein Intake: A Metabolomics Approach within the PREDIMED Study. Mol Nutr Food Res. 2020:e2000178. doi:10.1002/mnfr.202000178
Katrinli S, Stevens J, Wani AH, et al. Evaluating the impact of trauma and PTSD on epigenetic prediction of lifespan and neural integrity. Neuropsychopharmacology. 2020. doi:10.1038/s41386-020-0700-5
Gentles AJ, Hui ABY, Feng W, et al. A human lung tumor microenvironment interactome identifies clinically relevant cell-type cross-talk. Genome Biol. 2020;21(1):107. doi:10.1186/s13059-020-02019-x
Jaimes C, Vajapeyam S, Brown D, et al. MR Imaging Correlates for Molecular and Mutational Analyses in Children with Diffuse Intrinsic Pontine Glioma. AJNR Am J Neuroradiol. 2020. doi:10.3174/ajnr.A6546